Ellington Management Group’s Medicines Co MDCO Stock Holding History

Ellington Management Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,100	Closed	-$282K	–	874
2019 Q1	$282K	Buy	+10,100	New	+$238K	0.05%	382
2018 Q2	–	Sell	-8,300	Closed	-$273K	–	992
2018 Q1	$273K	Buy	+8,300	New	+$259K	0.02%	629
2016 Q1	–	Sell	-9,600	Closed	-$358K	–	783
2015 Q4	$358K	Buy	+9,600	New	+$363K	0.13%	229
2014 Q1	–	Sell	-7,300	Closed	-$282K	–	824
2013 Q4	$282K	Sell	7,300 -13,300	-65%	-$476K	0.1%	335
2013 Q3	$691K	Buy	+20,600	New	+$656K	0.13%	196

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Ellington Management Group's MDCO Position: Q2 2019 in Review

Ellington Management Group sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 10,100 shares — an estimated $282K sold.

Ellington Management Group first reported a position in MDCO in Q3 2013 and held it in 5 quarters. The position peaked at $691K in Q3 2013. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

Ellington Management Group reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
Ellington Management Group sold 10,100 Medicines Co shares in Q2 2019, an estimated $282K.
Ellington Management Group first reported a position in Medicines Co in Q3 2013 and held it in 5 quarters.
Ellington Management Group's Medicines Co position peaked at $691K in Q3 2013.
228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.